Class II · Moderate risk
Solifenacin Succinate Tablets 5mg
CGMP Deviations
Is Solifenacin recalled?
Yes — there is an active recall. 2 ongoing FDA recalls mention Solifenacin (6 total). Check the affected lots below.
Most common reason: cGMP deviation (5 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Solifenacin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Solifenacin recalls on record
none so far in 2026; 6 on record, newest first
Class II · Moderate risk
Solifenacin Succinate Tablets 10MG
CGMP Deviations
Class II · Moderate risk
Solifenacin Succinate Tablets
CGMP Deviations
Class II · Moderate risk
Solifenacin Succinate Tablets
CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.
Class II · Moderate risk
Solifenacin Succinate Tablets
CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.
Class II · Moderate risk
SOLIFENACIN SUCCINATE Tablet
Labeling: Label Mixup; SOLIFENACIN SUCCINATE Tablet, 5 mg may be potentially mislabeled as BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, NDC 00574010601, Pedigree: W003754, EXP: 6/26/2014.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.